Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Heart stent showdown: ultimaster vs. the rest in 1,000 patients

NCT ID NCT02719106

Disease control Sponsor: Duk-Woo Park, MD Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how well the Ultimaster stent works compared to other stents used to open blocked heart arteries. About 1,000 adults with coronary artery disease who received the Ultimaster stent were followed to track deaths, heart attacks, and the need for repeat procedures. The goal was to see if the Ultimaster stent is as safe and effective as other options in everyday medical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

1,000 people

The number who actually took part.

Started

Jul 2016

Finished

Aug 2024

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

patients with Ultimaster stent

Ages

19 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 19 and more * Intervention with Ultimaster stent * Agreed with written informed consent form Exclusion Criteria: * Intervention with Ultimaster stent and other drug eluting stent at the same time * Life expectancy of 1year and under * Cardiac shock

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronary artery disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coronary artery disease

Contacts and locations

Locations

  • Asan Medical Center

    Seoul, South Korea

  • Daegu Catholic University Medical Center

    Daegu, South Korea

  • Gangneung Asan Hospital

    Gangneung, South Korea

  • Gangwon National Univ. Hospital

    Chuncheon, South Korea

  • Inje University Ilsan Paik Hospital

    Ilsan, South Korea

  • Keimyung University Dongsan Medical Center

    Daegu, South Korea

  • Kwangju Christian Hospital

    Kwangju, South Korea

  • Pusan National University Hospital

    Pusan, South Korea

  • Sejong General hospital

    Bucheon-si, South Korea

  • The Catholic Univ. of Korea Seoul St. Mary's hospital

    Seoul, South Korea

  • The Catholic University of Korea St. Paul's Hospital

    Seoul, South Korea

  • The Catholic University of Korea St. Vincent's Hospital

    Suwon, South Korea

  • The Catholic University of Korea, Yeouido St. Mary's Hospital

    Seoul, South Korea

  • Ulsan University Hospital

    Ulsan, South Korea

  • Wonju Severance Christian Hospital

    Wŏnju, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.